Skip to main content

Table 4 Treatment patterns: patients with no flares and with flares occurring during follow-up of 12 months (N = 19,369)

From: Gout treatment and comorbidities: a retrospective cohort study in a large US managed care population

Ever during 12 months No flares Total (any flare) 1 flare 2 flares 3 flares
after index date    (n = 19,369) (n = 15,893) (n = 2,790) (n = 686)
  n % n % n % n % n %
NSAIDS 58325 36.9% 15730 81.2% 12821 80.7% 2338 83.8% 571 83.2%
   selective 10110 6.4% 2345 12.1% 1795 11.3% 430 15.4% 120 17.5%
   nonselective 53750 34.0% 15076 77.8% 12278 77.3% 2245 80.5% 553 80.6%
Colchicine 19353 12.2% 10333 53.3% 7929 49.9% 1855 66.5% 549 80.0%
Corticosteroids 28379 17.9% 8845 45.7% 6695 42.1% 1666 59.7% 484 70.6%
Probenecid 1781 1.1% 729 3.8% 503 3.2% 174 6.2% 52 7.6%
Allopurinol 44110 27.9% 12434 64.2% 9662 60.8% 2170 77.8% 602 87.8%
No treatment 69241 43.7% 0 0.0% 0 0.0% 0 0.0% 0 0.0%